Oxaliplatin, irinotecan, and fluorouracil in the prolonged regimen for the Ist-line therapy of metastatic colorectal cancer: New therapy regimen.

Authors:

Abstract
E14617 Background: Treatment of colorectal cancer patients (CRC, pts) with multiple large metastases is a great challenge. New chemotherapy regimen includes combination of Oxaliplatin, Irinotecan and Fluorouracil in prolonged regimen for the Ist line therapy of CRC. Methods: 18 pts with histologically verified diagnosis (adenocarcinoma) were enrolled in the study. All pts had multiple large metastases in liver and/or lungs. Size of metastases reached 4-10 cm (8 pts) and 10-18 cm (5 pts). Therapy regimen: Oxaliplatin 65 mg/m2, Irinotecan 100 mg/m2, i.v. every 2 weeks, Fluorouracil 200 mg/m2/day, continuous infusion, on days 1-14 with 2 weeks intervals. 102 courses were completed. Average number of courses – 6. Results: Complete (CR) or partial (PR) remission was achieved in 17 (94.4%) of total 18 pts. CR was registered in 3 pts: 2 of them underwent surgery (hemi-hepatectomy) after 5 and 9 therapy courses. Follow up period of CR pts was 22 mon+, 20 mon+, 7 mon+. PR was noted in 14 pts: progression-free peri...